Prudential Financial’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Prudential Financial’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-4,280	Closed	-$484K	–	2415
2017 Q2	$484K	Hold	4,280	–	–	﹤0.01%	2036
2017 Q1	$429K	Hold	4,280	–	–	﹤0.01%	2068
2016 Q4	$460K	Buy	4,280 +110	+3%	+$12.9K	﹤0.01%	2051
2016 Q3	$519K	Hold	4,170	–	–	﹤0.01%	2001
2016 Q2	$443K	Hold	4,170	–	–	﹤0.01%	2034
2016 Q1	$477K	Buy	+4,170	New	+$489K	﹤0.01%	2004

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Prudential Financial's CBPO Position: Q3 2017 in Review

Prudential Financial sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2017, closing a stake of 4,280 shares — an estimated $484K sold.

Prudential Financial first reported a position in CBPO in Q1 2016 and held it in 6 quarters. The position peaked at $519K in Q3 2016. 94 funds tracked by Wall St. Rank hold CBPO as of Q3 2017.

Prudential Financial reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2017 after selling out during the quarter.
Prudential Financial sold 4,280 China Biologic Products Holdings, Inc. shares in Q3 2017, an estimated $484K.
Prudential Financial first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and held it in 6 quarters.
Prudential Financial's China Biologic Products Holdings, Inc. position peaked at $519K in Q3 2016.
94 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2017.

Based on Prudential Financial's 13F filing for Q3 2017, filed 2 Nov 2017.